A detailed history of Db Fitzpatrick & Co, Inc transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Db Fitzpatrick & Co, Inc holds 3,352 shares of TMO stock, worth $1.88 Million. This represents 1.84% of its overall portfolio holdings.

Number of Shares
3,352
Previous 3,398 1.35%
Holding current value
$1.88 Million
Previous $1.88 Million 10.32%
% of portfolio
1.84%
Previous 1.75%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$531.86 - $624.21 $24,465 - $28,713
-46 Reduced 1.35%
3,352 $2.07 Million
Q2 2024

Jul 17, 2024

SELL
$541.52 - $599.02 $11,371 - $12,579
-21 Reduced 0.61%
3,398 $1.88 Million
Q1 2024

Apr 19, 2024

SELL
$528.82 - $599.43 $30,671 - $34,766
-58 Reduced 1.67%
3,419 $1.99 Million
Q4 2023

Jan 23, 2024

BUY
$431.41 - $532.94 $225,196 - $278,194
522 Added 17.66%
3,477 $1.85 Million
Q3 2023

Nov 01, 2023

BUY
$498.29 - $574.41 $39,364 - $45,378
79 Added 2.75%
2,955 $1.5 Million
Q2 2023

Aug 09, 2023

SELL
$508.46 - $591.13 $67,116 - $78,029
-132 Reduced 4.39%
2,876 $1.5 Million
Q1 2023

Apr 24, 2023

BUY
$535.0 - $604.82 $28,890 - $32,660
54 Added 1.83%
3,008 $1.73 Million
Q4 2022

Jan 24, 2023

SELL
$484.71 - $571.37 $38,776 - $45,709
-80 Reduced 2.64%
2,954 $0
Q3 2022

Oct 20, 2022

SELL
$507.19 - $604.49 $204,397 - $243,609
-403 Reduced 11.73%
3,034 $1.54 Million
Q2 2022

Jul 28, 2022

BUY
$500.9 - $612.21 $4,508 - $5,509
9 Added 0.26%
3,437 $1.87 Million
Q1 2022

Apr 22, 2022

BUY
$524.0 - $644.92 $33,012 - $40,629
63 Added 1.87%
3,428 $2.03 Million
Q4 2021

Feb 03, 2022

BUY
$569.0 - $667.24 $1.91 Million - $2.25 Million
3,365 New
3,365 $2.25 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $220B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Db Fitzpatrick & Co, Inc Portfolio

Follow Db Fitzpatrick & Co, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Db Fitzpatrick & Co, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Db Fitzpatrick & Co, Inc with notifications on news.